<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="144540">
  <!-- This xml conforms to an XML Schema at:
    http://clinicaltrials.gov/ct2/html/images/info/public.xsd
 and an XML DTD at:
    http://clinicaltrials.gov/ct2/html/images/info/public.dtd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on June 04, 2014</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>http://clinicaltrials.gov/show/NCT01797185</url>
  </required_header>
  <id_info>
    <org_study_id>CLR_11_04</org_study_id>
    <secondary_id>CLR_11_04</secondary_id>
    <nct_id>NCT01797185</nct_id>
  </id_info>
  <brief_title>A Clinical Evaluation Of The Safety Of Baclofen Er Capsules (Grs) When Administered Once Daily To Subjects With Spasticity Due To Multiple Sclerosis (Ms): An Open Label, Long Term, Safety Trial</brief_title>
  <official_title>A CLINICAL EVALUATION OF THE SAFETY OF BACLOFEN ER CAPSULES (GRS) WHEN ADMINISTERED ONCE DAILY TO SUBJECTS WITH SPASTICITY DUE TO MULTIPLE SCLEROSIS (MS): AN OPEN LABEL, LONG TERM, SAFETY TRIAL</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Sun Pharma Advanced Research Company Limited</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Sun Pharma Advanced Research Company Limited</source>
  <oversight_info>
    <authority>United States: Food and Drug Administration</authority>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      This is a multicenter, open-label, safety trial in subjects with spasticity due to MS.
      Approximately 200 subjects will be enrolled in approximately 30-35 centers, in order to
      obtain safety data from at least 100 subjects who have completed at least 26 weeks of
      treatment. An attempt will be made to enroll at least 20 subjects who will be baclofen-naïve
      at entry.

      Subjects enrolled in clinical trial CLR_09_21 who complete the double-blind randomized
      withdrawal phase (Part 3) of that trial will be eligible to participate in this trial.  In
      addition, subjects not enrolled in trial CLR_09_21 who are on a stable daily dose (same
      total daily dose of baclofen for at least 30 days prior to enrollment) of baclofen immediate
      release (IR), as well as baclofen-naïve subjects will be eligible to participate in this
      trial.

      Subjects enrolled in this trial who did not participate in CRL_09_21 will receive open label
      Baclofen ER Capsules (GRS). Subjects who enroll in this trial and participated in the
      double-blind phase of study CRL_09_21 will temporarily receive blinded study medication
      during the first 4 weeks which will be dispensed using an electronic drug-dispensing system
      (IVRS/IWRS).
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      All subjects will undergo safety assessments at Screening (Visit 1), Baseline (Visit 2),
      Week 4 (Visit 3), Week 12 (Visit 4), Week 26 (Visit 5) and all follow-up visits conducted
      every three months
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date>April 2013</start_date>
  <completion_date type="Anticipated">May 2014</completion_date>
  <primary_completion_date type="Anticipated">May 2014</primary_completion_date>
  <phase>Phase 3</phase>
  <study_type>Interventional</study_type>
  <study_design>Endpoint Classification: Safety Study, Intervention Model: Single Group Assignment, Masking: Open Label</study_design>
  <primary_outcome>
    <measure>No. of participants with adverse events</measure>
    <time_frame>26 weeks</time_frame>
    <safety_issue>Yes</safety_issue>
  </primary_outcome>
  <primary_outcome>
    <measure>No. of participants with adverse vital signs</measure>
    <time_frame>26 weeks</time_frame>
    <safety_issue>Yes</safety_issue>
  </primary_outcome>
  <primary_outcome>
    <measure>Number of participants with adverse laboratory parameters</measure>
    <time_frame>26 weeks</time_frame>
    <safety_issue>Yes</safety_issue>
  </primary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Anticipated">100</enrollment>
  <condition>Spasticity</condition>
  <arm_group>
    <arm_group_label>Baclofen ER</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>The subjects will receive Baclofen capsules</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Baclofen</intervention_name>
    <description>Subjects enrolled following the completion of protocol CLR_09_21 will receive daily doses of Baclofen ER Capsules (GRS) as follows:
Subjects who were randomized to Baclofen ER Capsules (GRS) in the double-blind part of study CLR_09_21 (Part 3) will continue to receive the same dose of baclofen as they received in study CLR_09_21.
Subjects who were randomized to placebo in the double-blind part of study CLR_09_21 (Part 3), will receive Baclofen ER Capsules (GRS) at a starting dose of 10 mg/day, titrated in 10 mg increments every 3 days up to the dose of Baclofen ER Capsules (GRS) that they received in open-label fixed GRS dose phase (Part 2) of study CLR_09_21.
Subjects enrolled in this study who participated in the double-blind phase of study CLR_09_21 will temporarily receive blinded study medication in the first 4 weeks dispensed according to the IVRS/IWRS.</description>
    <arm_group_label>Baclofen ER</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        -  Willingness to participate and give written informed consent

          -  Men and women ≥ 18 years of age

          -  Sexually active women who are of child bearing potential will practice an acceptable
             method of birth control for the duration of the trial as judged by the investigator.
             Examples of acceptable contraception are: condoms, foams, jellies, diaphragm,
             intrauterine device, oral or long-acting injected contraceptives, bilateral tubal
             ligation, bilateral oophorectomy, hysterectomy, or having a partner who is incapable
             of initiating conception. The practice of contraception must have started at least 3
             months prior to trial entry.

          -  If female, negative pregnancy test result at Screening

          -  Diagnosed with MS and a known history of spasticity

          -  Meet one of the following criteria

               -  Subjects who completed the double-blind randomized withdrawal phase (Part 3) of
                  trial CLR_09_21 with no major protocol violation

               -  Subjects who are newly diagnosed with spasticity due to MS with no history of
                  treatment using any anti-spasticity medications, or, with a history of
                  spasticity due to MS but with no previous exposure to baclofen treatment

               -  Subjects who are receiving a stable baclofen IR dose (ie, a dose of 10 mg to 80
                  mg daily, having started at least 30 days prior to enrollment)
      </textblock>
    </criteria>
    <gender>Both</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>90 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Brian a Peterson, CCRC</last_name>
    <role>Principal Investigator</role>
  </overall_official>
  <location>
    <facility>
      <name>Neurological Physicians of Arizona/Clinical Research Advantage</name>
      <address>
        <city>Gilbert</city>
        <state>Arizona</state>
        <zip>85234</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Kelly Crotte, CCRC</last_name>
      <phone>480-610-0177</phone>
      <email>kcrotte@crastudies.com</email>
    </contact>
    <contact_backup>
      <last_name>William Grainger, MD</last_name>
      <phone>480-305-5716</phone>
      <email>wgrainger@crastudies.com</email>
    </contact_backup>
  </location>
  <location>
    <facility>
      <name>NSS Clinical Research, LLC</name>
      <address>
        <city>Tucson</city>
        <state>Arizona</state>
        <zip>85741</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Brian a Peterson, CCRC</last_name>
      <phone>520-742-1833</phone>
      <email>bpeterson@neuroresearch.com</email>
    </contact>
    <contact_backup>
      <last_name>David Weidman, MD</last_name>
      <phone>520-742-1833</phone>
      <email>dweidman@nwneuro.com</email>
    </contact_backup>
  </location>
  <location>
    <facility>
      <name>Advanced Neurosciences Research, LLC</name>
      <address>
        <city>Fort Collins</city>
        <state>Colorado</state>
        <zip>80528</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Active, not recruiting</status>
  </location>
  <location>
    <facility>
      <name>Multiple Sclerosis Treatment Center</name>
      <address>
        <city>Derby</city>
        <state>Connecticut</state>
        <zip>6418</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Cheryl Michaud</last_name>
      <phone>203-732-1290</phone>
      <email>mstc@griffinhealth.org</email>
    </contact>
    <contact_backup>
      <last_name>Joseph Guarnaccia, MD</last_name>
      <phone>203-732-1290</phone>
      <email>mstreatmentcenters@griffinhealth.org</email>
    </contact_backup>
  </location>
  <location>
    <facility>
      <name>Coastal Connecticute Research, LLC</name>
      <address>
        <city>New London</city>
        <state>Connecticut</state>
        <zip>06320</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jessie Jellison, LPN</last_name>
      <phone>860-437-7092</phone>
      <email>jessie@ccrstudies.com</email>
    </contact>
    <contact_backup>
      <last_name>Laurence Radin, MD</last_name>
      <phone>860-437-7092</phone>
      <email>jessie@ccrstudies.com</email>
    </contact_backup>
  </location>
  <location>
    <facility>
      <name>Georgetown University Hospital</name>
      <address>
        <city>Washington</city>
        <state>District of Columbia</state>
        <zip>20007</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jessica Kim</last_name>
      <phone>202-444-4289</phone>
      <email>jfk51@georgetown.edu</email>
    </contact>
    <contact_backup>
      <last_name>Carlo Tornatore, MD</last_name>
      <phone>202-444-2658</phone>
      <email>tornatoc@gunet.georgetown.edu</email>
    </contact_backup>
  </location>
  <location>
    <facility>
      <name>Bradenton Research Center, Inc.</name>
      <address>
        <city>Bradenton</city>
        <state>Florida</state>
        <zip>34205</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Amy Hamilton, LPN</last_name>
      <phone>941-708-0005</phone>
      <email>amyhamilton@bradentonresearch.com</email>
    </contact>
    <contact_backup>
      <last_name>William McElveen</last_name>
      <phone>941-708-0005</phone>
      <email>cebmce@hotmail.com</email>
    </contact_backup>
  </location>
  <location>
    <facility>
      <name>Advanced Medical Pain Management &amp; Research Clinic</name>
      <address>
        <city>Miami</city>
        <state>Florida</state>
        <zip>33145</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Withdrawn</status>
  </location>
  <location>
    <facility>
      <name>Neurology Associates of Ormond Beach</name>
      <address>
        <city>Ormond Beach</city>
        <state>Florida</state>
        <zip>32174</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Sandra Geyer, CCRC</last_name>
      <phone>386-673-2500</phone>
      <email>neurosgeyer@yahoo.com</email>
    </contact>
    <contact_backup>
      <last_name>James Scott, MD</last_name>
      <phone>386-673-2500</phone>
      <email>neurojscott@yahoo.com</email>
    </contact_backup>
  </location>
  <location>
    <facility>
      <name>Neurostudies, Inc.</name>
      <address>
        <city>Port Charlotte</city>
        <state>Florida</state>
        <zip>33952</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Vicky Thursby</last_name>
      <phone>941-743-1027</phone>
      <email>neurostudies3@daystar.net</email>
    </contact>
    <contact_backup>
      <last_name>Liliana Montoya, MD</last_name>
      <phone>941-743-1027</phone>
      <email>neurostudies4@daystar.net</email>
    </contact_backup>
  </location>
  <location>
    <facility>
      <name>University of South Florida</name>
      <address>
        <city>Tampa</city>
        <state>Florida</state>
        <zip>33612</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Angela Aungst</last_name>
      <phone>813-974-6378</phone>
      <email>aaungst@health.usf.edu</email>
    </contact>
    <contact_backup>
      <last_name>Derrick Robertson, MD</last_name>
      <phone>813-974-6378</phone>
      <email>droberts@health.usf.edu</email>
    </contact_backup>
  </location>
  <location>
    <facility>
      <name>Shepherd Center</name>
      <address>
        <city>Atlanta</city>
        <state>Georgia</state>
        <zip>30309</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Ismari clesson, RN</last_name>
      <phone>404-350-7651</phone>
      <email>Ismari_Clesson@shepherd.org</email>
    </contact>
    <contact_backup>
      <last_name>Ben Thrower, MD</last_name>
      <phone>404-352-2020</phone>
      <email>ben_thrower@shepherd.org</email>
    </contact_backup>
  </location>
  <location>
    <facility>
      <name>Emory University</name>
      <address>
        <city>Atlanta</city>
        <state>Georgia</state>
        <zip>30322</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Kanoa Folami</last_name>
      <phone>404-778-3772</phone>
      <email>kfolami@emory.edu</email>
    </contact>
    <contact_backup>
      <last_name>Niel Lava, MD</last_name>
      <phone>404-778-3444</phone>
      <email>nlava@emory.edu</email>
    </contact_backup>
  </location>
  <location>
    <facility>
      <name>Rowe Neurology Institute</name>
      <address>
        <city>Lenexa</city>
        <state>Kansas</state>
        <zip>66214</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Leigh Kreshel, MS</last_name>
      <phone>913-894-1500</phone>
      <email>lkreshel@neurokc.com</email>
    </contact>
    <contact_backup>
      <last_name>Vernon Rowe, III, MD</last_name>
      <phone>913-894-1500</phone>
      <email>vrowe@neurokc.com</email>
    </contact_backup>
  </location>
  <location>
    <facility>
      <name>Norton Neurology MS Services</name>
      <address>
        <city>Louisville</city>
        <state>Kentucky</state>
        <zip>40207</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Diana Godwin, RN</last_name>
      <phone>502-899-6782</phone>
      <email>diana.godwin@nortonhealthcare.org</email>
    </contact>
    <contact_backup>
      <last_name>Robert Tillet Jr., MD</last_name>
      <phone>502-899-6782</phone>
      <email>rtilletjr@gmail.com</email>
    </contact_backup>
  </location>
  <location>
    <facility>
      <name>Johns Hopkins</name>
      <address>
        <city>Baltimore</city>
        <state>Maryland</state>
        <zip>21287-6985</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Sandra Cassard, ScD</last_name>
      <phone>913-894-1500</phone>
      <email>scassar1@jhmi.edu</email>
    </contact>
    <contact_backup>
      <last_name>John Ratchford</last_name>
      <phone>410-614-5835</phone>
      <email>jratchf1@jhmi.edu</email>
    </contact_backup>
  </location>
  <location>
    <facility>
      <name>Henry Ford Health System, Department of Neurology</name>
      <address>
        <city>Detroit</city>
        <state>Michigan</state>
        <zip>48202</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jackie Reuther, RN, CCRC</last_name>
      <phone>313-916-1906</phone>
      <email>jreuthe1@hfhs.org</email>
    </contact>
    <contact_backup>
      <last_name>Mirela Cerghet, MD, PhD</last_name>
      <phone>313-916-7207</phone>
      <email>mcerghe1@hfhs.org</email>
    </contact_backup>
  </location>
  <location>
    <facility>
      <name>University of Missouri Department of Physical Medicine and Rehabilitation</name>
      <address>
        <city>Columbia</city>
        <state>Missouri</state>
        <zip>65212</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Anne Bonnett, RN</last_name>
      <phone>573-884-6119</phone>
      <email>bonnetta@health.missouri.edu</email>
    </contact>
    <contact_backup>
      <last_name>Michael Acuff, MD</last_name>
      <phone>573-882-3101</phone>
      <email>acuffm@health.missouri.edu</email>
    </contact_backup>
  </location>
  <location>
    <facility>
      <name>University of Nebraska Medical Center (UNMC) Neurological Sciences</name>
      <address>
        <city>Omaha</city>
        <state>Nebraska</state>
        <zip>68198-2045</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>LuAnn Larson</last_name>
      <phone>402-559-8555</phone>
      <email>llarson@unmc.edu</email>
    </contact>
    <contact_backup>
      <last_name>Rana Zabad, MD</last_name>
      <phone>402-559-5569</phone>
      <email>rzabad@unmc.edu</email>
    </contact_backup>
  </location>
  <location>
    <facility>
      <name>University of Rochester</name>
      <address>
        <city>Rochester</city>
        <state>New York</state>
        <zip>14643</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Eileen Scheid, RN</last_name>
      <phone>585-275-6673</phone>
      <email>eileen_scheid@urmc.rochester.edu</email>
    </contact>
    <contact_backup>
      <last_name>Andrew Goodman</last_name>
      <phone>585-275-7854</phone>
      <email>andrew_goodman@urmc.rochester.edu</email>
    </contact_backup>
  </location>
  <location>
    <facility>
      <name>Burke Rehabilitation Hospital</name>
      <address>
        <city>White Plains</city>
        <state>New York</state>
        <zip>10605</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Rosanna Cirio, MA</last_name>
      <phone>914-597-2476</phone>
      <email>rcirio@burke.org</email>
    </contact>
    <contact_backup>
      <last_name>Argyrios Stampas</last_name>
      <phone>914-597-2837</phone>
      <email>astampas@burke.org</email>
    </contact_backup>
  </location>
  <location>
    <facility>
      <name>University of North Carolina at Chapel Hill Department of Neurology</name>
      <address>
        <city>Chapel Hill</city>
        <state>North Carolina</state>
        <zip>27599</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Manisha Chopra</last_name>
      <phone>919-843-7857</phone>
      <email>chopram@neurology.unc.edu</email>
    </contact>
    <contact_backup>
      <last_name>Silvia Markovic-Plese, MD</last_name>
      <phone>919-966-7857</phone>
      <email>markovics@neurology.unc.edu</email>
    </contact_backup>
  </location>
  <location>
    <facility>
      <name>PMG Research of Winston-Salem</name>
      <address>
        <city>Winston-Salem</city>
        <state>North Carolina</state>
        <zip>27103</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Beth Friedman, CCRC</last_name>
      <phone>336-794-8165</phone>
      <email>efriedman@pmg-research.com</email>
    </contact>
    <contact_backup>
      <last_name>Isaac Mitchell, MD</last_name>
      <phone>336-794-8165</phone>
      <email>efriedman@pmg-research.com</email>
    </contact_backup>
  </location>
  <location>
    <facility>
      <name>Altru Health System/Altru Clinic-Main</name>
      <address>
        <city>Grand Forks</city>
        <state>North Dakota</state>
        <zip>58201</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Withdrawn</status>
  </location>
  <location>
    <facility>
      <name>Neurology &amp; Associates, Inc.</name>
      <address>
        <city>Akron</city>
        <state>Ohio</state>
        <zip>44320</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Patricia Schisler, LPN, CCRC</last_name>
      <phone>330-572-1011</phone>
      <email>pschisler@nnadoc.com</email>
    </contact>
    <contact_backup>
      <last_name>Jose Rafecas, MD</last_name>
      <phone>330-572-1011</phone>
      <email>jrafecas@nnadoc.com</email>
    </contact_backup>
  </location>
  <location>
    <facility>
      <name>The Ohio State University Medical Center</name>
      <address>
        <city>Columbus</city>
        <state>Ohio</state>
        <zip>43212</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Erin Marshall</last_name>
      <phone>614-366-3752</phone>
      <email>erin.marshall@osumc.edu</email>
    </contact>
    <contact_backup>
      <last_name>Aaron Boster, MD</last_name>
      <phone>614-366-3752</phone>
      <email>aaron.boster@osumc.edu</email>
    </contact_backup>
  </location>
  <location>
    <facility>
      <name>Lynn Health Science Institute</name>
      <address>
        <city>Oklahoma City</city>
        <state>Oklahoma</state>
        <zip>73112</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Phyllis Fahrenhruch</last_name>
      <phone>405-602-3073</phone>
      <email>pmorris@lhsi.net</email>
    </contact>
    <contact_backup>
      <last_name>Mark fisher, MD</last_name>
      <phone>405-602-3927</phone>
      <email>mfisher@lhsi.net</email>
    </contact_backup>
  </location>
  <location>
    <facility>
      <name>OMRF MS Center of Excellence</name>
      <address>
        <city>Oklahoma City</city>
        <state>Oklahoma</state>
        <zip>73104</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Micki Moore</last_name>
      <phone>405-271-6241</phone>
      <email>micki-moore@omrf.org</email>
    </contact>
    <contact_backup>
      <last_name>Gabriel Pardo, MD</last_name>
      <phone>(405) 271 6241</phone>
      <email>gabriel-pardo@omrf.org</email>
    </contact_backup>
  </location>
  <location>
    <facility>
      <name>Penn State University College of Medicine/MS Hershey Medical Center</name>
      <address>
        <city>Hershey</city>
        <state>Pennsylvania</state>
        <zip>17033</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Bendra Geiger, Geiger</last_name>
      <phone>717-531-7591</phone>
      <email>bgeiger@hmc.psu.edu</email>
    </contact>
    <contact_backup>
      <last_name>Elizabeth Lucassen, MD</last_name>
      <phone>717-531-1804</phone>
      <email>elucassen@hmc.psu.edu</email>
    </contact_backup>
  </location>
  <location>
    <facility>
      <name>Thomas Jefferson University</name>
      <address>
        <city>Philadelphia</city>
        <state>Pennsylvania</state>
        <zip>19107</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Lindsay Liszewski</last_name>
      <phone>215-955-9575</phone>
      <email>lindsay.liszewski@jefferson.edu</email>
    </contact>
    <contact_backup>
      <last_name>Thomas Leist, MD</last_name>
      <phone>215-955-6871</phone>
      <email>Thomas.leist@jefferson.edu</email>
    </contact_backup>
  </location>
  <location>
    <facility>
      <name>Neurology Clinic, P.C.</name>
      <address>
        <city>Cordova</city>
        <state>Tennessee</state>
        <zip>38018</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Ye Liu, CCRC</last_name>
      <phone>901-866-9252</phone>
      <email>yliu@neuroclinic.org</email>
    </contact>
    <contact_backup>
      <last_name>Barbara Cape O'Brien, MD</last_name>
      <phone>901-747-1111</phone>
      <email>blcobrien@hotmail.com</email>
    </contact_backup>
  </location>
  <location>
    <facility>
      <name>Future Search Trials of Neurology, LP</name>
      <address>
        <city>Austin</city>
        <state>Texas</state>
        <zip>78731</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Natalie Hussung</last_name>
      <phone>512-380-9925</phone>
      <email>natalieh@fstrials.com</email>
    </contact>
    <contact_backup>
      <last_name>John Hudson, MD</last_name>
      <phone>512-380-9925</phone>
      <email>jdh@sleepdoc.net</email>
    </contact_backup>
  </location>
  <location>
    <facility>
      <name>Cardiovascular &amp; Neurosciences Research Institute, ProHealth Care, Inc.</name>
      <address>
        <city>Waukesha</city>
        <state>Wisconsin</state>
        <zip>53188</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Active, not recruiting</status>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>February 2014</verification_date>
  <lastchanged_date>February 17, 2014</lastchanged_date>
  <firstreceived_date>February 16, 2013</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>baclofen, spasticity</keyword>
  <is_fda_regulated>Yes</is_fda_regulated>
  <is_section_801>Yes</is_section_801>
  <has_expanded_access>No</has_expanded_access>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Multiple Sclerosis</mesh_term>
    <mesh_term>Muscle Spasticity</mesh_term>
    <mesh_term>Sclerosis</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Baclofen</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
